USD10
TARA Shares
About Protara TherapeuticsProtara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

USD10
TARA Shares
About Protara TherapeuticsProtara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Stats

TRADING WINDOW

Closed

OPENS AT

Aug 28 at 1:30 PM GMT+0

MARKET CAP

$235.79M

OPEN PRICE

Not enough data

LOW (1Y)

$3.02

HIGH (1Y)

$7.82

LOW (24H)

$3.83

HIGH (24H)

$4.05

VOLUME (24H)

$136.32K

69.42%

Price history

Time
Price
Change
Today
Not enough data
Not enough data
1 Day
$3.95
1.01%
1 Week
$3.94
1.32%
1 Month
$3.89
2.57%
1 Year
$3.12
27.88%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.